THERAVANCE BIOPHARMA INC

CUSIP: 88339KAA0 Class: NOTE

PRELUDE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001387508)

Note: Option positions (PUT/CALL) are excluded.

Q3 2021
Shares 150,000 Value ($000) $139 Avg Close — Range —